Edition:
United States

Albemarle Corp (ALB)

ALB on New York Consolidated

90.12USD
8 Dec 2016
Change (% chg)

$1.32 (+1.49%)
Prev Close
$88.80
Open
$90.00
Day's High
$91.00
Day's Low
$89.53
Volume
73,576
Avg. Vol
1,120,065
52-wk High
$91.00
52-wk Low
$45.78

Latest Key Developments (Source: Significant Developments)

Albemarle signs agreement for exclusive exploration, acquisition rights to lithium resource in Argentina
Monday, 12 Sep 2016 05:05pm EDT 

Albemarle Corp : Albemarle signs agreement for exclusive exploration and acquisition rights to lithium resource in Argentina .Entered into an agreement with Bolland Minera S.A., for exclusive exploration and acquisition rights to a lithium resource in Antofalla.  Full Article

Albemarle to acquire lithium salts production assets in Asia
Tuesday, 23 Aug 2016 06:50am EDT 

Albemarle Corp : Albemarle signs definitive agreement to acquire lithium salts production assets in Asia . Albemarle Corp says transaction includes manufacturing assets located in both Jiangxi and Sichuan . Says transaction is expected to close by end of Q1 of 2017 .Says collectively, Jiangli new material assets have a total lithium salts capacity of 15,000 mt/year, with ability to expand.  Full Article

Albemarle Q2 adjusted EPS $0.93 from cont ops
Wednesday, 3 Aug 2016 05:05pm EDT 

Albemarle Corp : Q2 adjusted earnings per share $0.93 from continuing operations . Q2 earnings per share $0.74 from continuing operations . Q2 revenue view $857.8 million -- Thomson Reuters I/B/E/S . Q2 loss per share $2.78 including items . Albemarle exceeds second quarter 2016 expectations and raises guidance . Q2 adjusted earnings per share $1.09 including items . Q2 sales fell 6.8 percent to $669.3 million . Q2 earnings per share view $1.00 -- Thomson Reuters I/B/E/S . Non-Cash tax charge of $416.7 million related to decision to sell chemetall surface treatment business in quarter . Sees fy net sales $2.5 - $2.8 billion .Sees 2016 adjusted eps (per diluted share) of $3.35 - $3.60.  Full Article

Fitch says Albemarle's planned sale of Chemetall surface treatment business to BASF is neutral to ratings
Friday, 17 Jun 2016 11:42am EDT 

Fitch Ratings :Fitch says Albemarle's planned sale of its Chemetall surface treatment business to BASF is neutral to co's ratings.  Full Article

Basf says basf to acquire global surface treatment provider chemetall
Friday, 17 Jun 2016 07:03am EDT 

Basf Se says :BASF to acquire global surface treatment provider Chemetall.  Full Article

Albemarle to sell Chemetall Surface Treatment Business to BASF for $3.2 bln
Friday, 17 Jun 2016 06:44am EDT 

Albemarle Corp: Albemarle enters into definitive agreement to sell Chemetall Surface Treatment Business to BASF for $3.2 billion .Albemarle corp says BofA Merrill lynch is acting as exclusive financial advisor to albemarle for the deal.  Full Article

Albemarle said to explore sale of $3 bln surface-treatment unit- Bloomberg
Friday, 13 May 2016 02:46pm EDT 

: Albemarle Corp said to explore sale of $3 billion surface-treatment unit - Bloomberg, citing sources .Bank Of America Corp has been hired to help Albemarle consider strategic options for Chemetall - Bloomberg, citing sources.  Full Article

Albemarle sets quarterly dividend of $0.305/share
Tuesday, 10 May 2016 06:01pm EDT 

Albemarle Corp :Sets quarterly dividend of $0.305 per share.  Full Article

Albemarle sees 2016 adjusted earnings per share $3.90-$4.25
Tuesday, 10 May 2016 05:35pm EDT 

Albemarle Corp : Lithium and advanced materials reported net sales of $216.2 million in Q1 of 2016, an increase of 8.8% . Albemarle corp says reported free cash flow is expected to range between $450 million and $550 million in 2016 . Sees 2016 adjusted earnings per share $3.90 to $4.25 . Fy2016 earnings per share view $3.67, revenue view $3.39 billion -- Thomson Reuters I/B/E/S . Albemarle Corp says Q1 total net sales unfavorably impacted by currency exchange as well as divestiture of flame retardants and specialty chemicals businesses . Refining solutions reported net sales of $170.6 million in Q1 of 2016, a decrease of 4.8% . Albemarle reports first quarter 2016 results and increases annual guidance . Q1 earnings per share $2.02 . Q1 sales $865.4 million versus I/B/E/S view $814.8 million . Q1 earnings per share view $0.85 -- Thomson Reuters I/B/E/S . Q1 adjusted earnings per share $1.12 .Sees 2016 sales $3.3 billion to $3.6 billion.  Full Article

Albemarle Corp CFO to take temporary medical leave of absence
Tuesday, 26 Jan 2016 06:45am EST 

Albemarle Corp:CFO to take temporary medical leave of absence.SVP and chief financial officer Scott A. Tozier will be on a temporary medical leave of absence, effective immediately.Anticipated that Scott a. tozier will return to his normal duties in the near future.In tozier's absence, other executive officers of co will assume tozier's management duties while remaining in their current positions.SVP of corporate strategy matthew juneau to assume management responsibility of co's finance,accounting,tax,treasury teams.  Full Article